BusinessNews

Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures

Oncology Healthcare platform ZenOnco.io has brought .4 million up in a seed round drove by Enzia Ventures

Oncology Healthcare platform ZenOnco.io has brought $1.4 million up in a seed round drove by Enzia Ventures, with participation from Better Capital, Apollo Hospitals, Titan Capital, Dr Arvind Kumar and other private backers.

Assets will be contributed to increase ZenOnco.io’s current operations and dispatch new items, said the organization in a public statement.

Established in 2019 by Dimple Parmar and Kishan Shah, ZenOnco.io expects to work on personal satisfaction and expand life for disease patients through integrative oncology therapy, which incorporates clinical treatment just as correlative treatment.

The platform has a group of onco-nutritionists, onco-therapists and physiotherapists to assist disease patients with secondary effects and indication the board to work on their personal satisfaction.

As per the Bengaluru-settled organization, it has collaborated with 200 emergency clinics, 1,500 oncologists, 200 analytic labs across India to give clinical treatment and have contacted in excess of 80,000 day to day routines and guided more than 20,000 lives.

Related posts
News

Cabinet Approves ₹10,000 Crore Startup India Fund of Funds 2.0 to Supercharge Venture Capital for Innovation

The Union Cabinet, led by Narendra Modi, has given the green light to a major new initiative aimed…
Read more
News

From AI to Bharat: Startup Summit Signals New Phase for India’s Innovation Landscape

Fortune India’s Startup Summit 2026 in Bengaluru drew founders, investors, policymakers and…
Read more
News

Embed brings next frontier of cashless ecosystem to US$11 billion Indian amusement industry

Embed brings next frontier of cashless ecosystem to US$11 billion Indian amusement industry At…
Read more
Newsletter
Become a Trendsetter
Sign up for Davenport’s Daily Digest and get the best of Davenport, tailored for you.